Round one of the the U.S. CRISPR patent battle is over – but what does the PTABS's no interference-in-fact decision really mean?

On 15 February 2017 the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trade Mark Office (USPTO) delivered judgment in the interference…
Go to Source
Author: Allen & Overy LLP

WordPress Video Lightbox
Cerca